Vernalis Research

Vernalis Research is a world leader in structure- and fragment-based drug discovery. We have generated six development candidates in the past six years and cell active lead compounds against 15 different targets. Our successes include projects in close collaboration with companies such as Lundbeck, Novartis, Servier, Genentech and Asahi Kasei Pharma. Our strengths are in developing and applying the most appropriate structure-based methods to work with our partners to solve problems in drug discovery.

For more information please visit www.vernalis-research.com

 

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch